GAM Systematic’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.88M Sell
50,986
-13,814
-21% -$492K 0.27% 120
2017
Q2
$2.5M Buy
64,800
+28,691
+79% +$1.05M 0.36% 69
2017
Q1
$1.23M Buy
36,109
+8,045
+29% +$264K 0.24% 149
2016
Q4
$921K Buy
28,064
+3,483
+14% +$113K 0.22% 177
2016
Q3
$793K Buy
24,581
+5,795
+31% +$188K 0.17% 260
2016
Q2
$580K Buy
18,786
+1,653
+10% +$51.7K 0.14% 296
2016
Q1
$513K Sell
17,133
-3,155
-16% -$87.1K 0.14% 307
2015
Q4
$562K Sell
20,288
-11,792
-37% -$335K 0.16% 266
2015
Q3
$979K Buy
+32,080
New +$1.12M 0.23% 169

Other funds holding EHC

GAM Systematic's EHC Position: Q3 2017 in Review

GAM Systematic reduced its Encompass Health (EHC) stake by 21% in Q3 2017, selling an estimated $492K and leaving 50,986 shares worth $1.88M. The position accounts for 0.27% of the portfolio, ranked #120.

GAM Systematic first reported a position in EHC in Q3 2015 and has held it in 9 quarters since. The position peaked at $2.5M in Q2 2017. 323 funds tracked by Wall St. Rank hold EHC as of Q3 2017.

  • GAM Systematic held 50,986 shares of Encompass Health worth $1.88M as of Q3 2017.
  • GAM Systematic sold 13,814 Encompass Health shares in Q3 2017, an estimated $492K.
  • Encompass Health made up 0.27% of GAM Systematic's portfolio in Q3 2017, its #120 holding.
  • GAM Systematic first reported a position in Encompass Health in Q3 2015 and has held it in 9 quarters since.
  • GAM Systematic's Encompass Health position peaked at $2.5M in Q2 2017.
  • 323 funds tracked by Wall St. Rank held Encompass Health as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.